Schön K - Search Results

1

Lack of J chain inhibits the transport of gut IgA and abrogates the development of intestinal antitoxic protection.

Lycke N, Erlandsson L, Ekman L, Schön K, Leanderson T. Lycke N, et al. Among authors: schon k. J Immunol. 1999 Jul 15;163(2):913-9. J Immunol. 1999. PMID: 10395687

2

Paradoxical IgA immunity in CD4-deficient mice. Lack of cholera toxin-specific protective immunity despite normal gut mucosal IgA differentiation.

Hörnquist CE, Ekman L, Grdic KD, Schön K, Lycke NY. Hörnquist CE, et al. Among authors: schon k. J Immunol. 1995 Sep 15;155(6):2877-87. J Immunol. 1995. PMID: 7673704

3

Local intravaginal vaccination of the female genital tract.

Wassén L, Schön K, Holmgren J, Jertborn M, Lycke N. Wassén L, et al. Among authors: schon k. Scand J Immunol. 1996 Oct;44(4):408-14. doi: 10.1046/j.1365-3083.1996.d01-320.x. Scand J Immunol. 1996. PMID: 8845036 Clinical Trial.

4

Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response.

Johansson M, Schön K, Ward M, Lycke N. Johansson M, et al. Among authors: schon k. Infect Immun. 1997 Mar;65(3):1032-44. doi: 10.1128/IAI.65.3.1032-1044.1997. Infect Immun. 1997. PMID: 9038313 Free PMC article.

5

Interferon-gamma receptor-deficient mice exhibit impaired gut mucosal immune responses but intact oral tolerance.

Kjerrulf M, Grdic D, Ekman L, Schön K, Vajdy M, Lycke NY. Kjerrulf M, et al. Among authors: schon k. Immunology. 1997 Sep;92(1):60-8. doi: 10.1046/j.1365-2567.1997.00312.x. Immunology. 1997. PMID: 9370925 Free PMC article.

6

Studies in knockout mice reveal that anti-chlamydial protection requires TH1 cells producing IFN-gamma: is this true for humans?

Johansson M, Schön K, Ward M, Lycke N. Johansson M, et al. Among authors: schon k. Scand J Immunol. 1997 Dec;46(6):546-52. doi: 10.1046/j.1365-3083.1997.d01-167.x. Scand J Immunol. 1997. PMID: 9420616 Free article.

7

Blockade of the B7-CD28 pathway by CTLA4-Ig counteracts rejection and prolongs survival in small bowel transplantation.

Kurlberg G, Haglind E, Schön K, Törnqvist H, Lycke N. Kurlberg G, et al. Among authors: schon k. Scand J Immunol. 2000 Mar;51(3):224-30. doi: 10.1046/j.1365-3083.2000.00725.x. Scand J Immunol. 2000. PMID: 10736090 Free article.

8

The ADP-ribosylating CTA1-DD adjuvant enhances T cell-dependent and independent responses by direct action on B cells involving anti-apoptotic Bcl-2- and germinal center-promoting effects.

Agren L, Sverremark E, Ekman L, Schön K, Löwenadler B, Fernandez C, Lycke N. Agren L, et al. Among authors: schon k. J Immunol. 2000 Jun 15;164(12):6276-86. doi: 10.4049/jimmunol.164.12.6276. J Immunol. 2000. PMID: 10843681

9

The B cell targeted adjuvant, CTA1-DD, exhibits potent mucosal immunoenhancing activity despite pre-existing anti-toxin immunity.

Lycke N, Schön K. Lycke N, et al. Among authors: schon k. Vaccine. 2001 Mar 21;19(17-19):2542-8. doi: 10.1016/s0264-410x(00)00487-4. Vaccine. 2001. PMID: 11257390

10

CTA1-DD-immune stimulating complexes: a novel, rationally designed combined mucosal vaccine adjuvant effective with nanogram doses of antigen.

Mowat AM, Donachie AM, Jägewall S, Schön K, Löwenadler B, Dalsgaard K, Kaastrup P, Lycke N. Mowat AM, et al. Among authors: schon k. J Immunol. 2001 Sep 15;167(6):3398-405. doi: 10.4049/jimmunol.167.6.3398. J Immunol. 2001. PMID: 11544331

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

158 results

Search Page

Filters